Cost of Patients With Hemophilia A and High-Titer Inhibitors in Colombia

Background: In Colombia, hemophilia is considered a high-cost disease, and hemophilia A with high-titer inhibitors may be responsible for a significant economic pressure on the Colombian health system. Objectives: To estimate the direct cost of care for patients with hemophilia A with high-titer i...

Full description

Saved in:
Bibliographic Details
Institution:FUCS -Fundación Universitaria de Ciencias de la Salud
Main Authors: Sánchez Vanegas, Guillermo, Linares, Adriana, Sarmiento, Isabel, Solano, María helena, Romano, Giancarlo, Castro, Carlos
Format: Artículo de revista
Language:English
Published: Elsevier 2019
Subjects:
Online Access:https://repositorio.fucsalud.edu.co/handle/001/3164
Tags: Add Tag
No Tags, Be the first to tag this record!